Abstract
FUNCTIONAL impairment and selective depletion of CD4+ T cells, the hallmark of AIDS, are at least partly caused by human immunodeficiency virus (HIV-1) type 1 binding to the CD4 molecule and infecting CD4+ cells1,2. It may, therefore, be of therapeutic value to target an antiviral agent to CD4+ cells to prevent infection and to inhibit HIV-1 production in patients' CD4+ cells which contain proviral DNA3,4. We report here that HIV-1 replication in normal primary CD4+ T cells can be inhibited by pokeweed antiviral protein, a plant protein of relative molecular mass 30,000 (ref. 5), which inhibits replication of certain plant RNA viruses6–8, and of herpes simplex virus, poliovirus and influenza virus9–11. Targeting pokeweed antiviral protein to CD4+ T cells by conjugating it to monoclonal antibodies reactive with CDS, CD7 or CD4 expressed on CD4+ cells, increased its anti-HIV potency up to 1,000-fold. HIV-1 replication is inhibited at picomolar concentrations of conjugates of pokeweed antiviral protein and monoclonal antibodies, which do not inhibit proliferation of normal CD4+ T cells or CD4-dependent responses. These conjugates inhibit HIV-1 protein synthesis and also strongly inhibit HIV-1 production in activated CD4+ T cells from infected patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Littman, D. R. A. Rev. Immun. 5, 561–587 (1987).
Dagliesh, A. G. et al. Nature 312, 763–767 (1984).
Schnittman, S. M. et al. Science 245, 305–308 (1989).
Psallidopoulos, M. C. et al. J. Virol. 63, 4626–4631 (1989).
Irvin, J. D. Pharmac. Ther. 21, 371–375 (1983).
Duggar, B. M. & Armstrong, J. K. Ann. Mo. Bot. Gard. 12, 359–364 (1925).
Wyatt, S. D. & Shepherd, R. J. Phytopathology 59, 1787–1792 (1969).
Tomlinson, J. A., Walker, V. M., Flewett, T. H. & Barclay, G. R. J. gen. Virol. 22, 225–230 (1974).
Aron, G. M. & Irvin, J. D. Antimicrob. Ag. Chemother. 17, 1032–1036 (1980).
Teltow, G. J., Irvin, J. D. & Aron, G. M. Antimicrob. Ag. Chemother. 23, 390–395 (1983).
Ussery, M. A., Irvin, J. D. & Hardesty, B. Ann. N.Y. Acad. Sci. 284, 431–437 (1977).
Uckun, F. M. et al. in Autologous Bone Marrow Transplantation (eds Dicke, K.A., Spitzer, G., Jagannath, S. & Evinger-Hodges, M. J.) 171–178 (Anderson, Houston, Texas, 1989).
Uckun, F. M. et al. in Membrane-mediated Cytotoxicity UCLA Symposium on Molecular and Cellular Biology. New Series (eds Gale, R. P. & Champlin, R.) 45, 243–256 (Liss, New York, 1987).
Ramakrishnan, S. & Houston, L. L. Cancer Res. 45, 2031–2036 (1985).
Uckun, F. M. et al. J. exp. Med. 163, 347–368, 1986.
Uckun, F. M. et al. Antibody. Immunocon. Radiopharm. 1, 247–262 (1988).
Linsley, P. S., Ledbetter, J. A., Kinney-Thomas, E. & Hu, S.-L. J. Virol. 62, 3695–3702 (1988).
Yarchoan, R. et al. Lancet i, 132 (1987).
Fischl, M. A. et al. New Engl. J. Med. 317, 185–191 (1987).
Poli, G., Orenstein, J. M., Kinter, A., Folks, M. & Fauci, A. S. Science 244, 575–577 (1989).
Obrig, T. G., Irvin, J. D. & Hardesty, B. Arch. Biochem. Biophys. 155, 278–283 (1973).
Garry, R. G. et al. Biosci. Rpts 8, 35–39 (1988).
Harper, M. E., Marselle, L. M., Gallo, R. C. & Wong-Staal, F. Proc. natn. Acad. Sci. U.S.A. 83, 772–776 (1986).
Hoxie, J. A. et al. Science 234, 1123–1127 (1986).
McDougal, J. S. et al. J. Immun. 135, 361–363 (1985).
Ledbetter, J. A. et al. Eur. J. Immun. 18, 525–532 (1988).
Till, M. A. et al. Science 242, 1166–1168 (1988).
Chaudhary, V. K. et al. Nature 335, 369–372 (1988).
Till, M. A. Proc. natn. Acad. Sci. U.S.A. (in the press).
Pincus, S. H., Wehrly, K. & Chesebro, B. J. Immun. 142, 3070–3075 (1989).
Starcich, B. R. et al. Cell 45, 637 (1986).
Weiss, R. A. et al. Nature 324, 572 (1986).
Uckun, F. M. et al. J. Immun. 135, 3817–3822 (1985).
Royston, I. et al. J. Immun. 125, 725–728 (1980).
Uckun, F. M. et al. J. Immun. 140, 2103–2111 (1985).
Uckun, F. M. et al. Cancer Res. 45, 69–75 (1988).
Ledbetter, J. A., Fell, H. P., Grosmaire, L. S., Norris, N. A. & Tsu, T. Molec. Immun. 24, 1255–1261 (1987).
Myers, D. E. et al. J. Immun. Meth. 121, 129–142 (1989).
Haffar, O., Dowbenko, D. & Berman, P. J. Cell Biol. 107, 1677–1687 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zarling, J., Moran, P., Haffar, O. et al. Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies. Nature 347, 92–95 (1990). https://doi.org/10.1038/347092a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/347092a0
This article is cited by
-
Partial characterization of a divergent isolate of pokeweed mosaic virus from Mississippi
Journal of Plant Pathology (2019)
-
Biological activities of ribosome-inactivating proteins and their possible applications as antimicrobial, anticancer, and anti-pest agents and in neuroscience research
Applied Microbiology and Biotechnology (2015)
-
Ribosome inactivating proteins from plants inhibiting viruses
Virologica Sinica (2011)
-
Gene transfer and expression of a non-viral polycation-based vector in CD4+ cells
Gene Therapy (1999)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.